Castle Biosciences, Inc. (CSTL)

USD 26.52

(-5.76%)

Total Debt Summary of Castle Biosciences, Inc.

  • Castle Biosciences, Inc.'s latest annual total debt in 2023 was 15.31 Million USD , up 15.03% from previous year.
  • Castle Biosciences, Inc.'s latest quarterly total debt in 2024 Q1 was 25.05 Million USD , up 63.64% from previous quarter.
  • Castle Biosciences, Inc. reported annual total debt of 13.31 Million USD in 2022, up 64.75% from previous year.
  • Castle Biosciences, Inc. reported annual total debt of 8.07 Million USD in 2021, down 0.0% from previous year.
  • Castle Biosciences, Inc. reported quarterly total debt of 25.05 Million USD for 2024 Q1, up 63.64% from previous quarter.
  • Castle Biosciences, Inc. reported quarterly total debt of 25.19 Million USD for 2024 Q2, up 0.55% from previous quarter.

Annual Total Debt Chart of Castle Biosciences, Inc. (2023 - 2017)

Historical Annual Total Debt of Castle Biosciences, Inc. (2023 - 2017)

Year Total Debt Total Debt Growth
2023 15.31 Million USD 15.03%
2022 13.31 Million USD 64.75%
2021 8.07 Million USD 0.0%
2020 - USD -100.0%
2019 25.12 Million USD 2.54%
2018 24.49 Million USD 31.7%
2017 18.6 Million USD 0.0%

Peer Total Debt Comparison of Castle Biosciences, Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 82.592%
Prenetics Global Limited 2.36 Million USD -546.158%
Star Equity Holdings, Inc. 3.6 Million USD -324.217%
CareDx, Inc 34.22 Million USD 55.261%
Exact Sciences Corporation 2.55 Billion USD 99.401%
Exagen Inc. 23.72 Million USD 35.458%
Inotiv, Inc. 417.64 Million USD 96.334%
Guardant Health, Inc. 1.35 Billion USD 98.869%
Biodesix, Inc. 60.69 Million USD 74.774%
BioNexus Gene Lab Corp. 133.39 Thousand USD -11377.192%
Precipio, Inc. 1.11 Million USD -1271.864%
iSpecimen Inc. 196.24 Thousand USD -7701.512%
Natera, Inc. 441.99 Million USD 96.536%
Aspira Women's Health Inc. 2.26 Million USD -575.64%
Standard BioTools Inc. 98.21 Million USD 84.411%
23andMe Holding Co. 76.51 Million USD 79.991%
Personalis, Inc. 48.96 Million USD 68.731%
Aclaris Therapeutics, Inc. 426 Thousand USD -3493.897%
Applied DNA Sciences, Inc. 1.23 Million USD -1136.912%
OpGen, Inc. 13.04 Million USD -17.375%
T2 Biosystems, Inc. 49.49 Million USD 69.069%
Myriad Genetics, Inc. 145 Million USD 89.441%
ICON Public Limited Company 3.93 Billion USD 99.611%
NeoGenomics, Inc. 611.67 Million USD 97.497%
Star Equity Holdings, Inc. 3.6 Million USD -324.217%
IDEXX Laboratories, Inc. 947.88 Million USD 98.385%
RadNet, Inc. 1.49 Billion USD 98.973%
MDxHealth SA 41.26 Million USD 62.898%
Psychemedics Corporation 2.29 Million USD -566.232%
Illumina, Inc. 2.26 Billion USD 99.323%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 83.725%
DarioHealth Corp. 29.54 Million USD 48.174%
Fulgent Genetics, Inc. 14.9 Million USD -2.703%
Sera Prognostics, Inc. 1.85 Million USD -724.004%
ENDRA Life Sciences Inc. 394.4 Thousand USD -3781.816%
OPKO Health, Inc. 326.56 Million USD 95.312%
Medpace Holdings, Inc. 142.12 Million USD 89.228%
Neogen Corporation 906.23 Million USD 98.311%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -1656.862%
Prenetics Global Limited 2.36 Million USD -546.158%
Mainz Biomed B.V. 7.42 Million USD -106.313%
bioAffinity Technologies, Inc. 1.57 Million USD -869.823%
Trinity Biotech plc 67.42 Million USD 77.294%
Neuronetics, Inc. 62.47 Million USD 75.494%
Sotera Health Company 2.32 Billion USD 99.342%
bioAffinity Technologies, Inc. 1.57 Million USD -869.823%